📧Email: service@nortrano.com


Couldn't load pickup availability
Free standard shipping on orders over $60
We can ship to virtually any address in the world. Note that there are restrictions on some products, and some products cannot be shipped to international destinations.
When you place an order, we will estimate shipping and delivery dates for you based on the availability of your items and the shipping options you choose. Depending on the shipping provider you choose, shipping date estimates may appear on the shipping quotes page.
Please also note that the shipping rates for many items we sell are weight-based. The weight of any such item can be found on its detail page. To reflect the policies of the shipping companies we use, all weights will be rounded up to the next full pound.
Pricing is for a monthly supply. Prescription medication. Medical evaluation required.
Tirzepatide is a dual action GLP-1 and GIP receptor agonist. It is the only medication of its kind currently used to support weight management. Most weight management medications target a single hormone pathway. Tirzepatide activates two: GLP-1, which slows digestion and helps regulate appetite, and GIP, which influences how your body responds to insulin and stores energy.
Together, these two pathways are why patients on tirzepatide often experience steadier appetite control, more consistent progress, and improved metabolic markers compared to single hormone therapies. Once weekly subcutaneous injection. Doses are gradually titrated by your provider to support tolerance.
Many patients describe broader lifestyle wins as their habits steady, including better sleep, more consistent meals, and a clearer sense of routine.
Most patients begin to feel changes in appetite within the first 1 to 2 weeks. Visible changes in weight typically follow over 8 to 16 weeks of consistent use, supported by hydration, protein intake, and movement habits guided by your provider. When side effects occur, they are usually mild to moderate gastrointestinal symptoms (nausea, constipation, indigestion) and tend to ease as your body adjusts.
Adults pursuing medical weight management whose BMI and medical history meet clinical eligibility criteria. A licensed Fitish provider reviews every intake before any prescription is issued.
Getting started takes minutes. You complete a short online intake about your health and goals. A licensed provider reviews it, and if tirzepatide is a fit, writes your prescription. Your medication ships discreetly from a licensed compounding pharmacy on a monthly cadence. From there, your care team stays with you through the patient portal for dose adjustments, questions, and ongoing support at no added cost.
Compounded tirzepatide is prepared by a state licensed sterile compounding pharmacy. Compounded medications are not FDA-approved and do not undergo FDA review for safety, effectiveness, or manufacturing quality. FDA-approved tirzepatide products (Mounjaro®, Zepbound®) are commercially available. Your provider may recommend compounded tirzepatide where clinically appropriate based on your evaluation.
Fitish RX offers two distinct GLP-1 lanes so you can match the program to your goal:
Both are provider led and ship monthly. If you are not sure which lane fits, complete your intake and your provider will recommend the right one.
These statements have not been evaluated by the Food and Drug Administration. Individual results vary. This product is not intended to diagnose, treat, cure, or prevent any disease.
Not a fit for compounded GLP-1? You may still qualify for our Microdosing program, a lower dose option designed for patients outside the standard BMI range. Eligibility for our compounded GLP-1 program is based on BMI and clinical criteria reviewed by a licensed provider. If your BMI falls below the threshold for compounded GLP-1, you may still be a candidate for our Microdosing program, a lower dose protocol built for patients seeking the metabolic, appetite, and longevity benefits of GLP-1 therapy at a gentler entry point. A provider will review your intake and recommend the program that fits your goals and health profile.
Compounded tirzepatide is tirzepatide prepared by a state licensed sterile compounding pharmacy and dispensed by prescription. Compounded medications are not FDA-approved. It is used for medically supervised weight management when a licensed provider determines it is appropriate.
$339 for a monthly supply. That price includes your provider consult, the medication if you are approved, and shipping. There are no separate consult or membership fees.
No. Fitish RX is direct-pay telehealth with transparent, all-in pricing. You do not need to involve insurance.
Tirzepatide is a once weekly subcutaneous injection. Your provider sets your starting dose and a gradual step-up plan, personalized to you and documented in your patient portal.
The most commonly reported side effects are mild to moderate gastrointestinal symptoms such as nausea, constipation, and indigestion, and they usually ease as your body adjusts. Starting at a low dose and increasing slowly helps. Your provider reviews the full safety profile with you before you begin.
You may still be a candidate for the Fitish Microdosing program, a lower dose option for patients outside the standard BMI range who want a gentler, cosmetic approach. Your provider recommends the program that fits your health profile after reviewing your intake.
New to GLP-1? Read our guide to weight loss shots and how they work.
For more detail, see The Clinic FAQ page or our Fitish RX Safety Information. The Black Box warnings, full side effect list, and drug interaction details remain in the Safety Details section below.


Thanks for subscribing!
This email has been registered!